Acumen Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $310.1M
Liabilities Breakdown FY2023
Total Liabilities: $43.2M
Asset Breakdown
Total Assets: $310.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $66.9M | 21.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $122.0K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $243.1M | 78.4% |
Liabilities Breakdown
Total Liabilities: $43.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.4M | 3.2% |
| Long-Term Debt | $29.9M | 69.3% |
| Other Liabilities | $11.9M | 27.5% |